Literature DB >> 24681293

MicroRNAs in vascular aging and atherosclerosis.

Rossella Menghini1, Robert Stöhr1, Massimo Federici2.   

Abstract

Lipid dysfunction, inflammation, immune response and advanced aging are major factors involved in the initiation and progression of atherosclerosis. MicroRNAs (miRNAs) have emerged as important regulators of gene expression that post transcriptionally modify cellular responses and function. MiRNA's are crucially involved in several vascular pathologies which show a clear association with increasing age (Dimmeler and Nicotera, 2013). Several studies have demonstrated that miRNA dysregulation has a crucial role in the development of atherosclerotic disease, encompassing every step from plaque formation to destabilization and rupture. This review will present the recent advances in the elucidation of the complex pathophysiological mechanisms in vascular aging by which miRNAs regulate the different phases of atherosclerotic process with a focus on endothelial cells and both, innate and adaptive immune systems. Furthermore, the future areas of research and potential clinical strategies will be discussed.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Endothelial dysfunction; Endothelial sencescence; Inflammation

Mesh:

Substances:

Year:  2014        PMID: 24681293     DOI: 10.1016/j.arr.2014.03.005

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  42 in total

Review 1.  MicroRNAs in cardiovascular ageing.

Authors:  Timon Seeger; Reinier A Boon
Journal:  J Physiol       Date:  2015-07-05       Impact factor: 5.182

Review 2.  microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts.

Authors:  Christian Schulte; Tanja Zeller
Journal:  Cardiovasc Diagn Ther       Date:  2015-02

3.  Nicotinamide mononucleotide (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation and anti-atherogenic effects.

Authors:  Tamas Kiss; Cory B Giles; Stefano Tarantini; Andriy Yabluchanskiy; Priya Balasubramanian; Tripti Gautam; Tamas Csipo; Ádám Nyúl-Tóth; Agnes Lipecz; Csaba Szabo; Eszter Farkas; Jonathan D Wren; Anna Csiszar; Zoltan Ungvari
Journal:  Geroscience       Date:  2019-08-28       Impact factor: 7.713

4.  MicroRNA-1907 enhances atherosclerosis-associated endothelial cell apoptosis by suppressing Bcl-2.

Authors:  Jin Zhao; Shu-Lin Ou; Wei-You Wang; Chang Yan; Lu-Xiang Chi
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

5.  Analysis of cardiovascular disease-related NF-κB-regulated genes and microRNAs in TNFα-treated primary mouse vascular endothelial cells.

Authors:  Hui Zhu; Yun Li; Mao-Xian Wang; Ju-Hong Wang; Wen-Xin Du; Fei Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2019 Oct.       Impact factor: 3.066

Review 6.  Diabetes and ageing-induced vascular inflammation.

Authors:  Mariam El Assar; Javier Angulo; Leocadio Rodríguez-Mañas
Journal:  J Physiol       Date:  2015-11-02       Impact factor: 5.182

7.  MicroRNAs and cancer: Key paradigms in molecular therapy.

Authors:  Weige Tan; Bodu Liu; Shaohua Qu; Gehao Liang; Wei Luo; Chang Gong
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

8.  Epigenetic regulation of L-type voltage-gated Ca2+ channels in mesenteric arteries of aging hypertensive rats.

Authors:  Jingwen Liao; Yanyan Zhang; Fang Ye; Lin Zhang; Yu Chen; Fanxing Zeng; Lijun Shi
Journal:  Hypertens Res       Date:  2016-11-24       Impact factor: 3.872

Review 9.  Mechanisms of Vascular Aging.

Authors:  Zoltan Ungvari; Stefano Tarantini; Anthony J Donato; Veronica Galvan; Anna Csiszar
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

Review 10.  Targeting vascular (endothelial) dysfunction.

Authors:  Andreas Daiber; Sebastian Steven; Alina Weber; Vladimir V Shuvaev; Vladimir R Muzykantov; Ismail Laher; Huige Li; Santiago Lamas; Thomas Münzel
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.